Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
BioLite, Inc.
National Cancer Institute (NCI)
Bristol-Myers Squibb
Beijing Biotech
Genmab
Cantargia AB
Beijing Biotech
Radiopharm Theranostics, Ltd
Beijing Biotech
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
Bristol-Myers Squibb
AstraZeneca
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
Dartmouth-Hitchcock Medical Center
AstraZeneca
H. Lee Moffitt Cancer Center and Research Institute
NeoImmuneTech
National Cancer Institute (NCI)
Tubulis GmbH
Sumitomo Pharma America, Inc.
Genmab
NEC Bio B.V
Yale University
Ohio State University Comprehensive Cancer Center
Exscientia AI Limited
Shenzhen Majory Biotechnology Co., Ltd.
Nanjing Leads Biolabs Co.,Ltd
Dana-Farber Cancer Institute
Amgen
AstraZeneca
Gilead Sciences
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Dana-Farber Cancer Institute
Jacobio Pharmaceuticals Co., Ltd.
Apollo Therapeutics Ltd
Big Ten Cancer Research Consortium
University Hospital, Grenoble
Seagen Inc.
Cedars-Sinai Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Transgene
Avenzo Therapeutics, Inc.
BicycleTx Limited
Pfizer
BicycleTx Limited